Olivier Tacca

Changes in and Prognostic Value of Hormone Receptor Status in a Series of Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Olivier Tacca, Frédérique Penault‐Llorca, Catherine Abrial et al. · The Oncologist · 2007 · 112 citations

Medicine, Oncology, Breast Oncology +14

Mammalian Target of Rapamycin Inhibitors in Combination with Letrozole in Breast Cancer

P. Chollet, Catherine Abrial, Olivier Tacca et al. · Clinical Breast Cancer · 2006 · 48 citations

Medicine, Oncology, Pharmacology +16

A New Prognostic Classification After Primary Chemotherapy for Breast Cancer: Residual Disease in Breast and Nodes (RDBN)

P. Chollet, Catherine Abrial, Xavier Durando et al. · The Cancer Journal · 2008 · 45 citations

Medicine, Oncology, Breast Oncology +16

Evaluation of TLC-NOSF dressing with poly-absorbent fibres in exuding leg ulcers: two multicentric, single-arm, prospective, open-label clinical trials

Michèle‐Léa Sigal, A. Addala, H. Maillard et al. · Journal of Wound Care · 2019 · 24 citations

Nursing, Surgery, Diabetic Foot Care +16

Metastatic Breast Cancer: Overall Survival Related to Successive Chemotherapies. What Do We Gain After the Third Line?

Olivier Tacca, Marianne Leheurteur, Xavier Durando et al. · Cancer Investigation · 2009 · 21 citations

Medicine, Oncology, Breast Oncology +13